| Date Filed | Type | Description |
| 09/17/2020 |
GN
| Aravive Appoints Michael W. Rogers to Board of Directors |
| 03/05/2019 |
GN
| Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR) |
| 03/04/2019 |
GN
| Detailed Research: Economic Perspectives on Huntsman, eHealth, Ionis Pharmaceuticals, Arch Capital Group, Copart, and Acorda Therapeutics — What Drives Growth in Today's Competitive Landscape |
| 11/08/2018 |
GN
| Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals — What Drives Growth in Today's Competitive Landscape |
| 10/17/2018 |
GN
| Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries — Discovering Underlying Factors of Influence |
| 05/02/2018 |
BW
| Acorda Provides Financial and Pipeline Update for First Quarter 2018 |
| 04/11/2018 |
BW
| Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018 |
| 03/13/2018 |
BW
| Acorda Therapeutics to Present at Oppenheimer Healthcare Conference |
| 02/15/2018 |
BW
| Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2017 |
| 02/02/2018 |
BW
| Acorda Fourth Quarter/Year End 2017 Update |
| 01/17/2018 |
GN
| Kessler Topaz Meltzer & Check, LLP - SHAREHOLDER REMINDER: Deadline in Class Action Lawsuit Filed Against Acorda Therapeutics, Inc. – ACOR |
| 01/11/2018 |
GN
| ACOR ALERT: Rosen Law Firm Reminds Acorda Therapeutics, Inc. Investors of Important January 17 Deadline in Class Action – ACOR |
| 01/06/2018 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACOR |
| 01/04/2018 |
GN
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) & Lead Plaintiff Deadline - January 17, 2018 |
| 01/03/2018 |
GN
| Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acorda Therapeutics, Inc. Shareholders |
| 12/26/2017 |
BW
| Acorda Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference |
| 12/21/2017 |
GN
| The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Acorda Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of January 17, 2018 |
| 12/18/2017 |
GN
| EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Acorda Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2018 ?? ACOR |
| 12/18/2017 |
GN
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Acorda Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit |
| 12/04/2017 |
GN
| The Klein Law Firm Announces a Class Action Filed on Behalf of Acorda Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of January 17, 2018 |
| 12/02/2017 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACOR |
| 11/30/2017 |
GN
| IMPORTANT ACORDA THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased and suffered losses in Acorda Therapeutics, Inc. |
| 11/29/2017 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acorda Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2018 – ACOR |
| 11/29/2017 |
GN
| ACORDA THERAPEUTICS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acorda Therapeutics, Inc. To Contact The Firm |
| 11/27/2017 |
GN
| Investor Expectations to Drive Momentum within Acorda Therapeutics, Ellie Mae, NutriSystem, Red Robin Gourmet Burgers, Group 1 Automotive, and ITT — Discovering Underlying Factors of Influence |
| 11/17/2017 |
GN
| Pomerantz Law Firm Announces the Filing of a Class Action against Acorda Therapeutics, Inc. and Certain Officers – ACOR |
| 11/15/2017 |
BW
| Acorda Provides Update on Tozadenant Development Program |
| 10/31/2017 |
BW
| Acorda Provides Financial and Pipeline Update for Third Quarter 2017 |
| 09/13/2017 |
BW
| Acorda to Present at the Cantor Fitzgerald Global Healthcare Conference |
| 09/01/2017 |
BW
| Acorda Adopts Shareholder Rights Plan |
| 07/27/2017 |
BW
| Acorda Provides Financial and Pipeline Update for Second Quarter 2017 |
| 07/13/2017 |
BW
| Acorda Second Quarter 2017 Update Webcast/Conference Call Scheduled for July 27, 2017 |
| 06/05/2017 |
BW
| CVT-301 Phase 3 Data Showed Significantly Improved Motor Function During OFF Periods in Parkinson??s Disease |
| 05/31/2017 |
BW
| Acorda to Present at the Goldman Sachs Healthcare Conference |
|